Molly E Klein

Dr. Molly E. Klein is an esteemed Associate Professor in the Department of Laboratory Medicine & Pathology at the University of Minnesota Medical School. With a profound expertise in anatomic pathology, her work primarily revolves around breast and gynecologic diseases. Dr. Klein is particularly renowned for her innovative approach in integrating technology into the diagnosis, prognosis, and therapeutic strategies for these diseases. Her research has significantly advanced the understanding of the Oncotype DX assay, a pivotal tool in making chemotherapy decisions for patients with estrogen receptor-positive breast cancers. Dr. Klein's investigations delve into the intricate correlations between traditional pathology markers and this commercial assay, shedding light on its clinical applications and limitations. Her dedication to quality assurance is evident in her studies addressing false negatives in HER2 detection within breast carcinoma, a critical aspect of accurate cancer diagnosis and treatment planning. Beyond her work with the Oncotype DX assay, Dr. Klein has contributed extensively to the broader field of pathology and oncology through her involvement in numerous research projects and scholarly publications. Her studies encompass a wide range of topics, including breast cancer, neoplasms, and the application of immunohistochemistry, reflecting her commitment to advancing medical knowledge and improving patient outcomes. Dr. Klein's contributions to the field are not only academic but also practical, as she continually seeks to bridge the gap between research and clinical practice. Her work has been instrumental in refining diagnostic techniques and enhancing the precision of therapeutic interventions, ultimately aiming to improve the quality of care for patients affected by breast and gynecologic cancers. As a thought leader in her field, Dr. Klein is dedicated to mentoring the next generation of pathologists and researchers. Her passion for education and research is evident in her active participation in academic conferences and her collaboration with fellow experts in pathology and oncology. Through her work, Dr. Klein continues to inspire and lead advancements in the understanding and treatment of complex diseases.